Article
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database.
Future oncology (London, England) - 1 Apr 2021
Kafatos George, Banks Victoria, Burdon Peter, Neasham David, Anger Caroline, Manuguid Fil, Lowe Kimberly A, Cheung Patrick, Taieb Julien, van Krieken Joannes Han
Abstract excerpt
Background: The literature on biomarker testing for metastatic colorectal cancer (mCRC) in Europe is scarce. This study aimed to estimate the percentage of mCRC patients from five European countries tested for biomarkers over time. Materials & methods: An oncology database was retrospectively analyzed; evaluated biomarkers were RAS, BRAF and microsatellite instability (MSI). The patients were drug treated during...
Topics
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor
- Colorectal Neoplasms
- Databases, Factual
- Europe
- Female
- Genetic Testing
- Humans
- Male
- Medical Oncology